Company / Revenue per Share
Phio Pharmaceuticals Corp. Revenue per Share History
FY2012-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.03
FY2020
5-year range
$0.01 / $0.40
FY2016-FY2020
Trend
-92.2%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has fluctuated over the past 7 years, ranging from $0.00 in FY2012 to $0.40 in FY2019.
Based on SEC 10-K filings.
0.03 in FY2020 with a 3-year CAGR of +29.0%.
Improved from $0.01 to $0.03 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +29.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, revenue per share decreased 92.2% year-over-year.
- Peak revenue per share was recorded in FY2019.
- Lowest revenue per share in the period was in FY2012.
Company context
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $0.03 | -92.2% |
| FY2019 | $0.40 | +6425.8% |
| FY2018 | $0.01 | -57.8% |
| FY2017 | $0.01 | +180.8% |
| FY2016 | $0.01 | -71.6% |
| FY2013 | $0.02 | +1799.0% |
| FY2012 | $0.00 | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026